论文部分内容阅读
目的:观察血必净注射液治疗急性呼吸窘迫综合征患者的临床效果,探讨其对患者呼吸功能的影响。方法:选取2010年01月~2014年02月急性呼吸窘迫综合征患者52例,将其分成实验组26例,对照组26例,两组患者均接受常规治疗方案,实验组在此基础上应用血必净注射液治疗,统计临床疗效。结果:治疗后实验组Murray评分、Marshall评分、PaO2/FiO2分别为(1.6±0.8)分、(2.9±2.7)分、(263.5±120.5)mmHg,以上指标均优于对照组,组间差异具有统计意义(P<0.05)。结论:血必净注射液治疗急性呼吸窘迫综合征患者,可有效改善其呼吸功能,提高生存质量。
Objective: To observe the clinical effect of Xuebijing Injection in the treatment of patients with acute respiratory distress syndrome (SARS) and explore its effect on respiratory function. Methods: Fifty-two patients with acute respiratory distress syndrome were selected from January 2010 to February 2014. They were divided into experimental group (n = 26) and control group (n = 26), and both groups received conventional treatment protocol. On the basis of the experimental group Xuebijing injection treatment, statistical clinical efficacy. Results: After treatment, the scores of Murray, Marshall and PaO2 / FiO2 in the experimental group were (1.6 ± 0.8), (2.9 ± 2.7) and (263.5 ± 120.5) mmHg, respectively. The above indexes were better than those in the control group Statistical significance (P <0.05). Conclusion: Xuebijing injection in the treatment of acute respiratory distress syndrome patients, can effectively improve their respiratory function, improve quality of life.